Pacific Biosciences Of California | PACB - Pre Tax Profit


Pacific Biosciences Of California reported $-40.17M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Agilent USD 364M 78M Dec/2025
Bruker USD 68.2M 140.8M Dec/2025
Danaher USD 1.24B 138M Mar/2026
General Electric Aerospace USD 2.2B 654M Mar/2026
Illumina USD 157M 220M Mar/2026
Myriad Genetics USD 4.6M 3.4M Dec/2025
Pacific Biosciences Of California USD -40.17M 2.55M Dec/2025
Quidel USD -79.5M 32.9M Mar/2026
Revvity USD 91.56M 35.88M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Standard Biotools USD -22.03M 10.87M Dec/2025
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
Waters USD 264.18M 94.06M Dec/2025